The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Alterations of the human gut microbiome in liver cirrhosis
Abstract
Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Here we characterize the gut microbiome in liver cirrhosis by comparing 98 patients and 83 healthy control individuals. We build a reference gene set for the cohort containing 2.69 million genes, 36.1% of which are novel. Quantitative metagenomics reveals 75,245 genes that differ in abundance between the patients and healthy individuals (false discovery rate < 0.0001) and can be grouped into 66 clusters representing cognate bacterial species; 28 are enriched in patients and 38 in control individuals. Most (54%) of the patient-enriched, taxonomically assigned species are of buccal origin, suggesting an invasion of the gut from the mouth in liver cirrhosis. Biomarkers specific to liver cirrhosis at gene and function levels are revealed by a comparison with those for type 2 diabetes and inflammatory bowel disease. On the basis of only 15 biomarkers, a highly accurate patient discrimination index is created and validated on an independent cohort. Thus microbiota-targeted biomarkers may be a powerful tool for diagnosis of different diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies in the past few years have demonstrated profound alterations of the intestinal microbiota in patients with cirrhosis, showing increased Enterobacteriacea as well as strains that are typically found in the oral microbiota, such as Veillonellaceae and Streptococcaceae, consistent with an invasion of microorganisms from the mouth to the gut in liver cirrhosis32,33.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [32]
In the citing paper
“Metagenomic studies have revealed substantial alterations in the composition of the gut microbiota in a range of CLD as well as in patients with cirrhosis12,32.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [32]
In the citing paper
“Key changes in the composition of the intestinal microbiota in cirrhosis include enrichment of Veillonella or Streptococcus as well as decreased bacteria from the order Clostridiales32.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [32]
In the citing paper
“Of note, the majority of the patient-enriched species were of buccal origin, suggesting an invasion of the gut from the mouth in liver cirrhosis32.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [32]
In the citing paper
“The gut microbiomes of patients with advanced liver disease and cirrhosis are characterized by an increase in potentially pathogenic bacteria, along with reduced numbers of bacteria with beneficial properties32,84,85.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [32]
In the citing paper
“Changes in the composition of the oral microbiome and the colonisation of the lower intestinal tract by oral-specific bacteria has been related to cirrhosis49.”
From Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice (2019) · cites this paper as [49]
In the citing paper
“Increased presence of Prevotella has been found in cirrhotics49”
From Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice (2019) · cites this paper as [49]
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Self-citationPrincipal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Self-citationLinking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,001
Phenotypical and Functional Polymorphism of Liver Resident Macrophages
Elchaninov, A. V., Fatkhudinov, T., Vishnyakova, P., Lokhonina, А. V., & Sukhikh, G. T. (2019) · Cells · doi:10.3390/cells8091032 · Cited by 68
Yang, Q., Wang, Y., Wei, X., Zhu, J., Wang, X., Xie, X., & Lü, W. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00286 · Cited by 67
Xie, G., Zheng, H., Qiu, Z., Lin, Z., Peng, Q., Girma, D., Elsheery, N. I., Lu, Y., Shen, C., Fu, J., et al. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2369 · Cited by 67
Intestinal flora plays a role in the progression of hepatitis-cirrhosis-liver cancer
Liu, S., & Yang, X. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1140126 · Cited by 67
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases
Thiele, M. S., Villesen, I. F., Niu, L., Johansen, S., Sulek, K., Nishijima, S., Espen, L. V., Keller, M. I., Israelsen, M. E., Suvitaival, T., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.03.035 · Cited by 67
Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver
Lutz, P. L. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.304 · Cited by 67
Alterations, Interactions, and Diagnostic Potential of Gut Bacteria and Viruses in Colorectal Cancer
Gao, R., Zhu, Y., Kong, C., Xia, K., Li, H., Zhu, Y., Zhang, X., Liu, Y., Zhong, H., Yang, R., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.657867 · Cited by 66
Self-citationDing, X., Lan, W., Yan, A., Li, Y., Katayama, Y., & Gu, J. (2021) · Journal of Environmental Management · doi:10.1016/j.jenvman.2021.114041 · Cited by 66
Circulating microbiome in patients with portal hypertension
Gedgaudas, R., Bajaj, J. S., Skiecevičienė, J., Varkalaitė, G., Jurkeviciute, G., Gelman, S., Valantienė, I., Zykus, R., Pranculis, A., Bang, C., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2029674 · Cited by 66
Yuan, Y., Wu, X., Zhang, X., Hong, Y., & Yan, H. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.01.007 · Cited by 66
Gut microbiome, microbial metabolites and the development of NAFLD
Caussy, C., & Loomba, R. S. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0058-x · Cited by 66
Ghosh, T. S., Arnoux, J., & O’Toole, P. W. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1822729 · Cited by 65
The Association Between Intestinal Bacteria and Allergic Diseases—Cause or Consequence?
Han, P., Gu, J., Li, L., Wang, X., Wang, H., Wang, Y., Chang, C. C.-C., & Sun, J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.650893 · Cited by 65
Self-citationA review of normalization and differential abundance methods for microbiome counts data
Swift, D. D., Cresswell, K. G., Johnson, R., Stilianoudakis, S., & Wei, X. (2022) · Wiley Interdisciplinary Reviews Computational Statistics · doi:10.1002/wics.1586 · Cited by 65
Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes
Ito, T., & Nguyen, M. H. (2023) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s347959 · Cited by 65
The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics
Saxami, G., Kerezoudi, E. N., Eliopoulos, C., Arapoglou, D., & Kyriacou, A. (2023) · Life · doi:10.3390/life13102023 · Cited by 65
Pan, M., Wan, C., Xie, Q., Huang, R., Tao, X., Shah, N. P., & Wei, H. (2015) · Journal of Dairy Science · doi:10.3168/jds.2015-10510 · Cited by 65
The Microbiome in Primary Sclerosing Cholangitis: Current Evidence and Potential Concepts
Hov, J., & Karlsen, T. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1608801 · Cited by 65
The Gut Microbiota-Host Partnership as a Potential Driver of Kawasaki Syndrome
Esposito, S., Polinori, I., & Rigante, D. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00124 · Cited by 65
Bozward, A. G., Warricker, F., Oo, Y. H., & Khakoo, S. I. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.643310 · Cited by 65
Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?
Jiang, L., & Schnabl, B. (2020) · Physiology · doi:10.1152/physiol.00005.2020 · Cited by 64
Deng, T., Li, J., He, B., Chen, B., Liu, F., Chen, Z., Zheng, J., Shi, Z., Zhang, T., Deng, L., et al. (2022) · Hepatology International · doi:10.1007/s12072-021-10279-3 · Cited by 64
Self-citationWang, T., Ishikawa, T., Sasaki, M., & Chiba, T. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.822190 · Cited by 64
A Survey of Statistical Methods for Microbiome Data Analysis
Lutz, K. C., Jiang, S., Neugent, M. L., Nisco, N. J. D., Zhan, X., & Li, Q. (2022) · Frontiers in Applied Mathematics and Statistics · doi:10.3389/fams.2022.884810 · Cited by 64
Gut Microbiota and Host Reaction in Liver Diseases
Fukui, H. (2015) · Microorganisms · doi:10.3390/microorganisms3040759 · Cited by 64
Metagenomic Analysis of Bacteria, Fungi, Bacteriophages, and Helminths in the Gut of Giant Pandas
Yang, S., Gao, X., Meng, J., Zhang, A., Zhou, Y., Long, M., Li, B., Deng, W., Jin, L., Zhao, S., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01717 · Cited by 64
Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis
Wang, Y., Gao, X., Zhang, X., Xiao, Y., Huang, J., Yu, D., Li, X., Hu, H., Ge, T., Li, D., et al. (2019) · mSystems · doi:10.1128/msystems.00463-19 · Cited by 64
High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients
Hu, J., Zhong, X., Yan, J., Zhou, D., Qin, D., Xiao, X., Zheng, Y., & Liu, Y. (2020) · BMC Nephrology · doi:10.1186/s12882-019-1668-4 · Cited by 64
Probiotics maintain the intestinal microbiome homeostasis of the sailors during a long sea voyage
Zhang, J., Zhao, J., Jin, H., Lv, R., Shi, H., De, G., Yang, B. K., Sun, Z., & Zhang, H. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1722054 · Cited by 64
Qi, Y., Wu, H., Yang, Z., Zhou, Y., Jin, L., Yang, M., & Wang, F. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-06837-2 · Cited by 63
Chen, Y., Li, Z., Hu, S., Zhang, J., Wu, J., Shao, N., Bo, X., Ni, M., & Ying, X. (2017) · Microbiome · doi:10.1186/s40168-017-0232-3 · Cited by 63
Self-citationThe Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies
Özdirik, B., Müller, T., Wree, A., Tacke, F., & Sigal, M. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136975 · Cited by 62
Yu, X. M., Jin, Y., Zhou, W., Xiao, T., Wu, Z., Su, J., Gao, H., Shen, P., Zheng, B., Luo, Q., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.761192 · Cited by 62
Self-citationHepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and Therapy
Luo, W., Guo, S., Zhou, Y., Zhao, J., Wang, M., Sang, L.-X., Chang, B., & Wang, B. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.873160 · Cited by 62
Microbiota and COVID-19: Long-term and complex influencing factors
Gang, J., Wang, H., Xue, X., & Zhang, S. J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.963488 · Cited by 62
Airway Microbiota and the Implications of Dysbiosis in Asthma
Durack, J., Boushey, H. A., & Lynch, S. V. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0631-8 · Cited by 62
Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice
Cabrera-Rubio, R., Patterson, A. M., Cotter, P. D., & Beraza, N. (2019) · Scientific Reports · doi:10.1038/s41598-019-48784-z · Cited by 61
Ragusa, M., Santagati, M., Mirabella, F., Lauretta, G., Cirnigliaro, M., Brex, D., Barbagallo, C., Domini, C., Gulisano, M., Barone, R. M. E., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176203 · Cited by 61
Gut Microbiome Characteristics in feral and domesticated horses from different geographic locations
Li, A., Vinderola, G., Endo, A., Kantanen, J., Jingfeng, C., Binetti, A. G., Burns, P., Qingmiao, S., Suying, D., Yu, Z., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03116-2 · Cited by 61
Self-citationYuan, X., Chang, C., Chen, X., & Li, K. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03009-8 · Cited by 60
The intestinal and biliary microbiome in autoimmune liver disease—current evidence and concepts
Liwinski, T., Heinemann, M., & Schramm, C. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00936-6 · Cited by 60
Role of the Microbiota in Lung Cancer: Insights on Prevention and Treatment
Pizzo, F., Maroccia, Z., Ferri, I. H., & Fiorentini, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116138 · Cited by 60
Wolstenholme, J. T., Saunders, J. M., Smith, M. L., Kang, J. D., Hylemon, P. B., González‐Maeso, J., Fagan, A., Zhao, D., Sikaroodi, M., Herzog, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34054-6 · Cited by 60
Phage therapy: Targeting intestinal bacterial microbiota for the treatment of liver diseases
Fujiki, J., & Schnabl, B. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100909 · Cited by 60
The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma
Sanduzzi‐Zamparelli, M., Rocco, A., Compare, D., & Nardone, G. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640617705576 · Cited by 60
Macnaughtan, J., Figorilli, F., García, E., Lu, H., Jones, H., Sawhney, R., Suzuki, K., Fairclough, S. J., Marsden, J. T., Moratalla, A., et al. (2020) · Nutrients · doi:10.3390/nu12061651 · Cited by 60
Targeting Dysbiosis for the Treatment of Liver Disease
Anand, G. S., Zarrinpar, A., & Loomba, R. S. (2016) · Seminars in Liver Disease · doi:10.1055/s-0035-1571276 · Cited by 59
Alterations of microbiota structure in the larynx relevant to laryngeal carcinoma
Gong, H., Shi, Y., Xiao, X., Cao, P., Wu, C., Tao, L., Hou, D., Wang, Y., & Zhou, L. F. (2017) · Scientific Reports · doi:10.1038/s41598-017-05576-7 · Cited by 59
Potential mechanisms linking gut microbiota and portal hypertension
Baffy, G. (2018) · Liver International · doi:10.1111/liv.13986 · Cited by 59
Wei, H., Wang, H., Tang, L., Mu, C., Ye, C., Chen, L., & Wang, C. (2019) · BMC Genomics · doi:10.1186/s12864-019-6219-7 · Cited by 59
Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis
Nishimura, N., Kaji, K., Kitagawa, K., Sawada, Y., Furukawa, M., Ozutsumi, T., Fujinaga, Y., Tsuji, Y., Takaya, H., Kawaratani, H., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136921 · Cited by 58
Luo, H., Li, M., Wang, F., Yang, Y., Wang, Q. L., Zhao, Y., Du, F., Chen, Y., Shen, J., Zhao, Q., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72600 · Cited by 58
Self-citationOral-gut connection: one step closer to an integrated view of the gastrointestinal tract?
Lira-Junior, R., & Boström, E. A. (2018) · Mucosal Immunology · doi:10.1038/mi.2017.116 · Cited by 58
Huang, R., Li, T., Ni, J., Bai, X., Gao, Y., Li, Y., Zhang, P., & Gong, Y. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01008 · Cited by 58
Gut-Liver Axis Links Portal Hypertension to Acute-on-Chronic Liver Failure
Trebicka, J., Reiberger, T., & Laleman, W. (2018) · Visceral Medicine · doi:10.1159/000490262 · Cited by 58
The Human Gut Virome in Hypertension
Han, M., Yang, P., Zhong, C., & Ning, K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03150 · Cited by 58
Zhang, S., Lin, L., Liu, W., Zou, B., Cai, Y., Liu, D., Xiao, D., Chen, J., Li, P., Zhong, Y., et al. (2019) · Nutrition Research · doi:10.1016/j.nutres.2019.10.001 · Cited by 57
Multimodal deep learning applied to classify healthy and disease states of human microbiome
Lee, S. J., & Rho, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-04773-3 · Cited by 57
Maiuolo, J., Carresi, C., Gliozzi, M., Mollace, R., Scarano, F., Scicchitano, M., Macrì, R., Nucera, S., Bosco, F., Oppedisano, F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073698 · Cited by 57
Zhang, C., Hu, A., Li, J., Zhang, F., Zhong, P., Li, Y., & Li, Y. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.830684 · Cited by 57
The pathogenesis of gut microbiota in hepatic encephalopathy by the gut–liver–brain axis
Zhu, R., Liu, L., Zhang, G., Dong, J., Ren, Z., & Li, Z. (2023) · Bioscience Reports · doi:10.1042/bsr20222524 · Cited by 57
Self-citationDong, W., Fan, X., Guo, Y., Wang, S., Jia, S., Lv, N., Tao, Y., Pan, Y., Xue, Y., Chen, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51864-y · Cited by 57
Wang, F., Kaplan, J. L., Gold, B. D., Bhasin, M., Ward, N. L., Kellermayer, R., Kirschner, B. S., Heyman, M. B., Dowd, S. E., Cox, S. B., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.088 · Cited by 57
Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis
Campion, D., Giovo, I., Ponzo, P., Saracco, G. M., Balzola, F. A., & Alessandria, C. (2019) · World Journal of Hepatology · doi:10.4254/wjh.v11.i6.489 · Cited by 57
Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome
Temraz, S. N., Nassar, F. J., Kreidieh, F., Mukherji, D., Shamseddine, A. I., & Nasr, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157800 · Cited by 57
Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact
Nishikawa, H., Enomoto, H., Nishiguchi, S., & Iijima, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041917 · Cited by 56
Comparison of Fecal Collection Methods on Variation in Gut Metagenomics and Untargeted Metabolomics
Guan, H., Pu, Y., Liu, C., Lou, T., Tan, S., Kong, M., Sun, Z., Mei, Z., Qi, Q., Quan, Z., et al. (2021) · mSphere · doi:10.1128/msphere.00636-21 · Cited by 56
Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived?
Abbas, N., Rajoriya, N., Elsharkawy, A. M., & Chauhan, A. (2022) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2022.2097070 · Cited by 56
Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review
Caley, L. R., White, H., de Goffau, M. C., Floto, R. A., Parkhill, J., Marsland, B. J., & Peckham, D. G. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07812-1 · Cited by 56
Li, C., Li, X., Guo, R., Ni, W., Liu, K., Liu, Z., Dai, J., Xu, Y., Abduriyim, S., Wu, Z., et al. (2023) · Microbiome · doi:10.1186/s40168-022-01448-z · Cited by 56
The gut microbiota-bile acid axis in cholestatic liver disease
Sun, D., Xie, C., Zhao, Y. M., Liao, J., Li, S., Zhang, Y., Wang, D., Hua, K., Gu, Y., Du, J., et al. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00830-x · Cited by 56
Lee, S., Arefaine, B., Begum, N., Stamouli, M., Witherden, E. A., Mohamad, M., Harzandi, A., Zamalloa, A., Cai, H., Williams, R. L., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.09.046 · Cited by 56
Microbiota—implications for immunity and transplantation
Bromberg, J. S., Fricke, W. F., Brinkman, C. C., Simon, T., & Mongodin, E. F. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.70 · Cited by 56
Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration
Sarangi, A. N., Goel, A., Singh, A., Sasi, A., & Aggarwal, R. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0683-9 · Cited by 56
Exploring the microbiome in health and disease
Scotti, E., Boué, S., Sasso, G. L., Zanetti, F., Belcastro, V., Poussin, C., Sierro, N., Battey, J. N. D., Gimalac, A., Ivanov, N. V., et al. (2017) · Toxicology Research and Application · doi:10.1177/2397847317741884 · Cited by 56
Predicting the recurrence of chronic rhinosinusitis with nasal polyps using nasal microbiota
Zhao, Y., Chen, J., Hao, Y. X., Wang, B., Wang, Y., Liu, Q., Zhao, J., Li, Y., Wang, P., Wang, X., et al. (2021) · Allergy · doi:10.1111/all.15168 · Cited by 56
Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction
Sauerbruch, T., Hennenberg, M., Trebicka, J., & Beuers, U. H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.718783 · Cited by 55
Oral Health and Liver Disease: Bidirectional Associations—A Narrative Review
Åberg, F. O., & Helenius‐Hietala, J. (2022) · Dentistry Journal · doi:10.3390/dj10020016 · Cited by 55
Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step
Fukui, H. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2017.00008 · Cited by 55
Wang, X., Tao, Y., Chen, W., Lv, Y., Hao, Z., Chen, J., Zhao, J., Wang, H., & Cai, Y. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i46.8128 · Cited by 55
Wakita, Y., Shimomura, Y., Kitada, Y., Yamamoto, H., Ohashi, Y., & Matsumoto, M. (2018) · BMC Microbiology · doi:10.1186/s12866-018-1311-8 · Cited by 55
Cheng, D., Song, J., Xie, M., & Song, D. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.07.044 · Cited by 55
Shared microbiological and immunological patterns in periodontitis and IBD: A scoping review
Baima, G., Massano, A., Squillace, E., Caviglia, G. P., Buduneli, N., Ribaldone, D. G., & Aimetti, M. (2021) · Oral Diseases · doi:10.1111/odi.13843 · Cited by 55
Sayavedra, L., Li, T., Batista, M. B., Seah, B. K. B., Booth, C., Zhai, Q., Chen, W., & Narbad, A. (2021) · Environmental Microbiology · doi:10.1111/1462-2920.15538 · Cited by 55
Metabolic fate of tea polyphenols and their crosstalk with gut microbiota
Wang, M., Li, J., Hu, T., & Zhao, H. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2021.12.003 · Cited by 55
Kim, H.-J., Worsley, O., Yang, E., Purbojati, R. W., Liang, A. L., Tan, W. L. W., Moses, D., Hartono, S., Fan, V. S. K., Lim, T. K. H., et al. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03114-4 · Cited by 54
Alterations in the Oral Microbiome Associated With Diabetes, Overweight, and Dietary Components
Shaalan, A., Lee, S., Féart, C., García‐Esquinas, E., Gómez-Cabrero, D., López‐García, E., Morzel, M., Neyraud, E., Rodríguez‐Artalejo, F., Streich, R., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.914715 · Cited by 54
Mukherjee, S., Chopra, A., Karmakar, S., & Bhat, G. S. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2339260 · Cited by 54
Wu, G. G., Zhang, C., Wu, H., Wang, R., Shen, J., Wang, L., Zhao, Y., Pang, X., Zhang, X., Zhao, L., et al. (2017) · mBio · doi:10.1128/mbio.02348-16 · Cited by 54
Remote Sensing Between Liver and Intestine: Importance of Microbial Metabolites
Fu, Z. D., & Cui, J. Y. (2017) · Current Pharmacology Reports · doi:10.1007/s40495-017-0087-0 · Cited by 54
Reciprocal interactions between bile acids and gut microbiota in human liver diseases
Ikegami, T., & Honda, A. (2017) · Hepatology Research · doi:10.1111/hepr.13001 · Cited by 54
Yun, Y., Chang, Y., Kim, H., Ryu, S., Kwon, M., Cho, Y. K., Kim, H., Cheong, H. S., & Joo, E. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020173 · Cited by 54
Characterisation of blood microbiota in patients with liver cirrhosis
Kajihara, M., Koido, S., Kanai, T., Ito, Z., Matsumoto, Y., Takakura, K., Saruta, M., Kato, K., Odamaki, T., Xiao, J., et al. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001494 · Cited by 54
Effect of probiotics on the intestinal microbiota of hemodialysis patients: a randomized trial
Liu, S., Liu, H., Chen, L., Liang, S., Shi, K., Meng, W., Xue, J., He, Q., & Jiang, H. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02207-2 · Cited by 54
Jiao, J., Lu, Z., Yu, Y., Ou, Y., Fu, M., Zhao, Y., Wu, N., Zhao, M., Liu, Y., Sun, Y. E., et al. (2021) · Parasites & Vectors · doi:10.1186/s13071-021-04740-3 · Cited by 54
Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease.
Bieghs, V., & Trautwein, C. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2014.12.04 · Cited by 54
Wu, X. F., Huang, S., Huang, J., Peng, P., Liu, Y., Han, B., & Sun, D. (2021) · Animals · doi:10.3390/ani11051247 · Cited by 53
Role of Microbiota in Viral Infections and Pathological Progression
Mizutani, T., Ishizaka, A., Koga, M., Tsutsumi, T., & Yotsuyanagi, H. (2022) · Viruses · doi:10.3390/v14050950 · Cited by 53
Zheng, H.-H., Du, C.-T., Yu, C., Tang, X.-Y., Huang, R., Zhang, Y., Gao, W., & Xie, G.-H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810928 · Cited by 53
Altered oral microbiota in chronic hepatitis B patients with different tongue coatings
Zhao, Y., Mao, Y., Tang, Y., Ni, M.-Z., Liu, Q., Wang, Y., Feng, Q., Peng, J., & Hu, Y. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i30.3448 · Cited by 53
Metadata
- Authors
- Qin, N., Yang, F., Li, A., Prifti, E., Chen, Y., Shao, L., Guo, J., Le Chatelier, E., Yao, J., Wu, L., Zhou, J., Ni, S., Liu, L., Pons, N., Batto, J. M., Kennedy, S. P., Leonard, P., Yuan, C., Ding, W., Chen, Y., Hu, X., Zheng, B., Qian, G., Xu, W., Ehrlich, S. D., Zheng, S., & Li, L.
- Affiliations
- First Affiliated Hospital Zhejiang University (CN)
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
- Guy's Hospital (GB)
- Corresponding author
- Ehrlich, S. Dusko
- Zheng, Shusen
- Li, Lanjuan
- ORCID
- Venue
- Nature
- Published
- 2014-07-23
- Volume
- 513
- Issue
- 7516
- Pages
- 59-64
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1964027278
- Cited by
- 2,177
- References
- 56
- Citations by year
- 2026: 136 · 2025: 174 · 2024: 215 · 2023: 214 · 2022: 226 · 2021: 283 · 2020: 235 · 2019: 201 · 2018: 161 · 2017: 136 · 2016: 98 · 2015: 83 · 2014: 10
- FWCI
- 44.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-11-DPBS-0001)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- liver cirrhosis, gut microbiota, microbiome biomarkers, oral bacteria, Veillonella, Streptococcus, diagnostic biomarkers, novel genes, type 2 diabetes, inflammatory bowel disease
- MeSH terms
- Chronic Disease, Diabetes Mellitus, Type 2, Feces, Genetic Markers, Health, Humans, Liver Cirrhosis, Mouth, Phylogeny, Reproducibility of Results, Inflammatory Bowel Diseases, Case-Control Studies, Gastrointestinal Tract, Metagenomics, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
